DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy

Information source: Virdi Eye Clinic
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Myopia

Intervention: Bromfenac (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Virdi Eye Clinic

Official(s) and/or principal investigator(s):
Navaneet S Borisuth, MD,PhD, Principal Investigator, Affiliation: Virdi Eye Clinic

Overall contact:
Cheryl Swanson, COT, Phone: 3097885524, Email: eyes@virdieyemd.com


This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.

Clinical Details

Official title: Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)

Study design: Time Perspective: Prospective

Primary outcome: Post-PRK pain

Secondary outcome: Post-PRK epithelial healing


Minimum age: 21 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- male or female at least 18 years of age,

- no other ocular studies with 15 days prior to dosing,

- BCVA 20/200 or better,

- return for study visits and follow instructions from investigator and staff,

- self administer test article

Exclusion Criteria:

- Ocular inflammation,

- hypersensitivity to bromfenac or nepafenac,

- any corneal pathology,

- have had radial keratotomy,

- corneal transplant or corneal refractive surgery in the last two years

Locations and Contacts

Cheryl Swanson, COT, Phone: 3097885524, Email: eyes@virdieyemd.com

Virdi Eye Clinic and Laser Vision Center, Rock Island, Illinois 61201, United States; Recruiting
Cheryl Swanson, COT, Phone: 309-788-5524, Email: eyes@virdieyemd.com
Susan Eaker, Phone: 3097885524, Email: eyes@virdieyemd.com
Navaneet S Borisuth, M.D., Ph.D., Principal Investigator
Matt Rauen, M.D., Sub-Investigator
Additional Information

Starting date: May 2011
Last updated: November 20, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017